Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022GlobeNewsWire • 12/12/22
Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life SciencesGlobeNewsWire • 12/08/22
Autolus Therapeutics announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysisGlobeNewsWire • 12/08/22
Autolus Therapeutics: Near-Term Catalyst Plus Several Bio Deals Could Shift MomentumSeeking Alpha • 11/16/22
Autolus Therapeutics to Present Three Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022GlobeNewsWire • 11/03/22
Autolus Therapeutics Reports Third Quarter 2022 Financial Results and Operational ProgressGlobeNewsWire • 11/03/22
Autolus Therapeutics to Report Third Quarter 2022 Financial Results on November 3, 2022GlobeNewsWire • 10/21/22
Moderna exercises option to license proprietary targeting technology from AutolusGlobeNewsWire • 10/12/22
Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus' Proprietary Safety Switch SystemGlobeNewsWire • 10/04/22
Autolus Therapeutics plc (AUTL) CEO Christian Itin on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/08/22
Correction - Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022GlobeNewsWire • 07/21/22
Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022GlobeNewsWire • 07/21/22
Autolus Therapeutics to Participate in William Blair's Biotech Focus Conference 2022, New York, July 12 – 13, 2022GlobeNewsWire • 07/06/22
Autolus Therapeutics Presents Clinical Data Updates at the European Hematology Association CongressGlobeNewsWire • 06/10/22
Autolus to hold Annual General Meeting (AGM) of Shareholders on Tuesday, June 28, 2022GlobeNewsWire • 05/31/22
Autolus Therapeutics to Participate in the Jefferies Healthcare Conference, being held in New York from June 8 – 10, 2022GlobeNewsWire • 05/27/22
Autolus Therapeutics to Present Four Clinical Data Updates at the European Hematology Association CongressGlobeNewsWire • 05/12/22
Autolus Therapeutics plc (AUTL) CEO Christian Itin on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/08/22
Autolus Therapeutics Reports First Quarter 2022 Financial Results and Operational ProgressGlobeNewsWire • 05/05/22
Autolus Therapeutics to Present Three Novel Cell Programming Approaches at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting, May 16-19, 2022GlobeNewsWire • 05/02/22